DXR - Daxor Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
541
-918
-1,012
1,835
-7,444
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
303
257
125
305
378
Total Operating Expenses
326
300
204
368
437
Operating Income or Loss
-
-
-
1,467
-7,881
Interest Expense
143
121
73
37
161
Total Other Income/Expenses Net
-
-
-
-
-
Income Before Tax
215
-1,218
-1,215
1,467
-7,881
Income Tax Expense
18
-333
25
12
1,266
Income from Continuing Operations
197
-886
-1,240
1,456
-9,146
Net Income
197
-886
-1,240
1,456
-9,146
Net Income available to common shareholders
197
-886
-1,240
1,456
-9,146
Reported EPS
Basic
-
-0.19
-0.33
0.33
-2.38
Diluted
-
-0.19
-0.33
0.33
-2.38
Weighted average shares outstanding
Basic
-
3,742
3,768
3,825
3,843
Diluted
-
3,742
3,768
3,825
3,843
EBITDA
-
-
-
-
-